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Kinetics of the porcine reproductive and respiratory syndrome virus
(PRRSV) humoral immune response in swine serum and oral fluids
collected from individual boars
Abstract
Background
The object of this study was to describe and contrast the kinetics of the humoral response in serum and oral
fluid specimens during acute porcine reproductive and respiratory syndrome virus (PRRSV) infection. The
study involved three trials of 24 boars each. Boars were intramuscularly inoculated with a commercial
modified live virus (MLV) vaccine (Trial 1), a Type 1 PRRSV field isolated (Trial 2), or a Type 2 PRRSV field
isolate (Trial 3). Oral fluid samples were collected from individual boars on day post inoculation (DPI) -7 and
0 to 21. Serum samples were collected from all boars on DPI −7, 0, 7, 14, 21 and from 4 randomly selected
boars on DPI 3, 5, 10, and 17. Thereafter, serum and oral fluid were assayed for PRRSV antibody using
antibody isotype-specific ELISAs (IgM, IgA, IgG) adapted to serum or oral fluid.
Results
Statistically significant differences in viral replication and antibody responses were observed among the three
trials in both serum and oral fluid specimens. PRRSV serum IgM, IgA, and IgG were first detected in samples
collected on DPI 7, 10, and 10, respectively. Oral fluid IgM, IgA, and IgG were detected in samples collected
between DPI 3 to 10, 7 to 10, and 8 to 14, respectively.
Conclusions
This study enhanced our knowledge of the PRRSV humoral immune response and provided a broader
foundation for the development and application of oral fluid antibody-based diagnostics.
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collected from individual boars
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Abstract
Background: The object of this study was to describe and contrast the kinetics of the humoral response in serum and
oral fluid specimens during acute porcine reproductive and respiratory syndrome virus (PRRSV) infection. The study
involved three trials of 24 boars each. Boars were intramuscularly inoculated with a commercial modified live virus (MLV)
vaccine (Trial 1), a Type 1 PRRSV field isolated (Trial 2), or a Type 2 PRRSV field isolate (Trial 3). Oral fluid samples were
collected from individual boars on day post inoculation (DPI) -7 and 0 to 21. Serum samples were collected from
all boars on DPI −7, 0, 7, 14, 21 and from 4 randomly selected boars on DPI 3, 5, 10, and 17. Thereafter, serum and oral
fluid were assayed for PRRSV antibody using antibody isotype-specific ELISAs (IgM, IgA, IgG) adapted to serum or
oral fluid.
Results: Statistically significant differences in viral replication and antibody responses were observed among the three
trials in both serum and oral fluid specimens. PRRSV serum IgM, IgA, and IgG were first detected in samples collected
on DPI 7, 10, and 10, respectively. Oral fluid IgM, IgA, and IgG were detected in samples collected between DPI 3 to 10, 7
to 10, and 8 to 14, respectively.
Conclusions: This study enhanced our knowledge of the PRRSV humoral immune response and provided a broader
foundation for the development and application of oral fluid antibody-based diagnostics.
Keywords: PRRSV, Oral fluid, ELISA, IgM, IgA, IgG, Antibody kinetics
Background
The presence of systemic and locally-produced antibodies
in oral fluid has led to its use as a diagnostic specimen for
a variety of infectious diseases. In humans, oral fluids have
been used in the diagnosis of human immunodeficiency
virus (HIV), Hepatitis A, B, and C viruses, measles,
mumps and other infectious diseases [1]. In swine, anti-
bodies against a variety of economically significant patho-
gens have been reported in oral fluids, including classical
swine fever virus [2,3], porcine circovirus type 2 [4], por-
cine reproductive and respiratory syndrome virus [5,6],
swine influenza virus [7], transmissible gastroenteritis
virus [8], Actinobacillus pleuropneumoniae [9], and E. coli
[10]. In large measure, the kinetics of the antibody re-
sponse against individual agents has not been described.
Therefore, the purpose of present study was to describe
and contrast the ontogeny of PRRSV IgM, IgA, and IgG
in oral fluids and serum specimens collected from indi-
vidually housed boars during acute PRRSV infection.
Results
PRRSV antibody isotypes in serum
The PRRSV antibody isotype (IgM, IgA, and IgG) re-
sponses in serum samples are shown in Figure 1 and
Table 1. Estimates for DPI −7, 0, 7, 14, 21 were based on
data from 72 boars, whereas estimates for DPIs 3, 5, 10,
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and 17 were based on a subset of 12 animals randomly
selected from the 72 boars. Based on pairwise comparisons,
statistically significant levels of IgM were detected by DPI 7,
peaked at DPI 14, and remained stable through DPI 21. In
contrast, statistically significant levels of IgA and IgG were
detected by DPI 10, after which they remained stable (IgA)
or increased significantly (IgG) through DPI 21. Further
analysis showed that IgM and IgA responses were associ-
ated with DPI (IgM: p < 0.0001, IgA: p < 0.0001), trial (IgM:
p < 0.0001, IgA: p < 0.0149), and the interaction between
trial and DPI (IgM: p < 0.0001, IgA: p < 0.0001). In contrast,
DPI (p < 0.0001) was the only factor associated with the
IgG response. Neither the age of the boar at the time of
inoculation nor the quantity of oral fluid collected from
each boar had a significant effect on IgM, IgA, or IgG.
PRRSV antibody isotype in oral fluid samples
The PRRSV antibody isotype (IgM, IgA, and IgG) re-
sponses in oral fluid samples are shown in Figure 2 and
Table 1 for oral fluid samples collected on DPI −7, 0–14,
17, and 21. Estimates were based on ≥66 oral fluid samples
at each sampling point. IgM S/P ratios were statistically
significant on DPI 7, peaked at DPI 11, and declined there-
after. Levels of IgA and IgG were significant on DPI 8 and
increased thereafter through the end of the experiment
(DPI 21). Factors significantly associated with IgM and IgA
S/P ratios included trial (IgM: p < 0.0001, IgA: p = 0.0273),
DPI (IgM: p < 0.0001, IgA: p < 0.0001), oral fluid volume
(IgM: p = 0.0002, IgA: p < 0.0001), and the interaction
between trial and DPI (IgM: p < 0.0001, IgA: p < 0.0001).
Factors associated with IgG included DPI (p < 0.0001) and
Figure 1 Kinetics of PRRSV antibody isotypes (IgM, IgA, and IgG) in serum based on responses in 72 boars inoculated with 3 different
PRRSV isolates. Results are reported as mean sample-to-positive (S/P) ratios and standard errors.
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the interaction of trial by DPI (p < 0.0001). Regardless of
isotype, boar age at the time of inoculation had no signifi-
cant effect on antibody response.
Comparison of PRRSV antibody responses in serum and
oral fluid
A comparison of the qualitative antibody response in
serum vs. oral fluid found no significant difference in the
proportion of ELISA positive results on DPI 0 – 14, 17,
and 21 (Table 2). No significant difference was detected
in the number of positive results for each pair-wise sam-
ple combination (serum vs. oral fluid) by trial, DPI, or
trial by DPI. On DPI 21, 100% of serum and oral fluid
samples were positive with mean S/P ratios of 1.69 (95%
Confidence Interval [CI]: 1.58, 1.79) and 2.60 (95% CI:
2.34, 2.86), respectively. An analysis of the quantitative
antibody isotype responses in serum and oral fluid sam-
ples using test results from samples collected on DPI −7,
0 – 14, 17, 21 estimated Pearson’s correlation coefficient
as r = 0.84, 0.78, and 0.90 for IgM, IgA, and IgG re-
sponses, respectively (Figure 3).
Comparison between viremia levels and antibody
responses
All serum samples from DPI −7 and 0 (n = 144) were
PRRSV qRT-PCR negative, whereas all serum samples
from boars tested on DPI 3 (n = 12) and DPI 7 (n = 72)
were positive. PRRSV was detected in oral fluids from 7
of 69 boars at DPI 1, 52 of 68 boars at DPI 2, 66 of 70 at
DPI 3, and all boars were PRRSV qRT-PCR positive at
DPI 4. A comparison of matched samples from individ-
ual boars showed that oral fluid was equal to serum for
the detection of PRRSV at DPI 7 and more likely to be
positive than serum on DPI 14 and 21. These data are
reported in detail elsewhere [11].
To evaluate the association between viremia and anti-
body responses, cumulative serum and oral fluid PRRSV
qRT-PCR (loge geq/μl) and antibody isotype (IgM, IgA,
IgG) responses over time were re-expressed as area
under the curve (AUC) (MedCalcW) prior to performing
the analyses. The mean qRT-PCR and antibody isotype
AUCs for serum and oral fluid are given in Table 3. Sta-
tistical analysis (ANOVA) of main effects showed sig-
nificant differences among trials (p < 0.001), sample type
(p < 0.001), and quantitative responses (PRRSV, IgM,
IgA, IgG; p < 0.001). With the exception of serum IgG,
statistically significant differences in means were de-
tected among trials both in the replication of PRRSVs
and in antibody responses (Tukey’s Honestly Significant
Difference (HSD) test). However, at the individual boar
level, correlation analysis found a weak association be-
tween PRRSV viremia AUC and serum IgM, IgA, or IgG
AUCs (r = 0.3762, 0.2915, and 0.0005). Likewise, the cor-
relation was weak between PRRSV oral fluid AUC and
Table 1 Porcine reproductive and respiratory syndrome virus (PRRSV) antibody isotypes (IgM, IgA, and IgG) in oral
fluid and serum samples collected from boars over day post inoculation (DPI)
DPI
Serum (mean S/P ratios) Oral fluid (mean S/P ratios)
Samples IgM IgA IgG Samples IgM IgA IgG
−7 72 0.10 d 0.35 b 0.03 d 70 0.02 g 0.15 g 0.01 i
0 72 0.19 d 0.31 b 0.03 d 68 0.02 g 0.08 g 0.01 i
1 - - - - 69 0.04 g 0.12 g 0.01 i
2 - - - - 68 0.04 g 0.13 g 0.02 i
3 12 0.05 d 0.23 b 0.01 d 70 0.07 g 0.16 g 0.02 i
4 - - - - 68 0.13 g 0.24 g 0.01 i
5 12 0.12 d 0.30 b 0.02 d 67 0.05 g 0.11 g 0.01 i
6 - - - - 66 0.09 g 0.12 g 0.01 i
7 72 0.82 c 0.58 b 0.05 d 69 0.30 f 0.23 g 0.03 i
8 - - - - 66 1.28 e 0.41 f 0.17 h
9 - - - - 66 2.32 c 0.95 e 0.59 g
10 12 3.56 b 1.70 a 0.87 c 70 2.72 b 1.45 b, c 0.99 f
11 - - - - 70 2.95 a 1.75 a 1.41 e
12 - - - - 70 2.70 b 1.59 a, b 1.78 d
13 - - - - 69 2.64 b 1.64 a 2.05 c
14 72 4.02 a 1.91 a 1.60 b 68 2.32 c 1.56 a, b 2.28 b
17 12 3.51 b 1.94 a 1.69 a, b 69 1.53 d 1.25 c, d 2.63 a
21 72 3.18 b 1.70 a 1.76 a 68 1.02 e 1.14 d, e 2.60 a
a-i Superscripts within columns indicate statistically significant differences among means (Tukey’s Honestly Significant Differences test, p < 0.05).
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Figure 2 Kinetics of PRRSV antibody isotypes (IgM, IgA, and IgG) in oral fluid based on responses in 70 boars inoculated with 3 different
PRRSV isolates. Results are reported as mean sample-to-positive (S/P) ratios and standard errors.
Table 2 Porcine reproductive and respiratory syndrome virus (PRRSV) seruma and oral fluidb ELISA qualitative resultsc
by day post inoculation (DPI)
Trial (virus isolate) Sample DPI 0 positive / tested DPI 7 positive / tested DPI 14 positive / tested DPI 21 positive / tested
Trial 1: (IngelvacW PRRS MLV)
Oral fluid 0 / 24 0 / 24 24 / 24 24 / 24
Serum 0 / 24 0 / 24 24 / 24 24 / 24
Trial 2: (Type 1, D09-012332)
Oral fluid 0 / 22 0 / 22 17 / 21 22 / 22
Serum 0 / 24 0 / 24 22 / 24 24 / 24
Trial 3: (Type 2, MN-184)
Oral fluid 0 / 24 0 / 23 24 / 24 22 / 22
Serum 0 / 24 0 / 24 24 / 24 24 / 24
Total
Oral fluid 0 / 70 0 / 69 65 / 69 68 / 68
Serum 0 / 72 0 / 72 70 / 72 72 / 72
a PRRS X3 Ab Test (IDEXX Laboratories, Inc, Westbrook, Maine, USA) performed according to the manufacturer’s instruction.
b PRRS X3 Ab Test (IDEXX Laboratories, Inc, Westbrook, Maine, USA) modified to detect anti-PRRSV antibody in oral fluid specimens [5].
c Samples with S/P ratio ≥ 0.4 were classified as positive.
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oral fluid IgM, IgA, or IgG AUCs (r = 0.3147, 0.2671,
and 0.2137).
Discussion
By definition, oral fluid is a mixture of saliva, oral muco-
sal transudate, and gingival crevicular fluid recovered
from the buccal cavity using an absorptive device [12].
Among a variety of other constituents, oral fluid contains
both locally-derived and systemic antibodies [13]. Thus,
pathogen-specific IgM, IgA, and IgG for PRRSV [5], influ-
enza A virus [7], and porcine circovirus type 2 [4] could
be detected in oral fluid samples collected from groups of
pigs (pens) under either experimental or field conditions.
The largest proportion of locally produced antibody con-
sists of dimeric secretory IgA (SIgA) produced by plasma
cells in salivary glands and duct-associated lymphoid
Figure 3 Correlation between serum and oral fluid PRRSV antibody isotypes (IgM, IgA, and IgG) based on results from individual boars.
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tissue (DALT) [14]. IgM and IgG are also produced in
these tissues, but the majority of IgM and IgG in oral fluid
is derived from serum via the gingival crevicular fluid [15].
In the present experiment, the collection of paired oral
fluid and serum samples from 72 individually-housed boars
inoculated with three different PRRSV isolates allowed for
a more comprehensive evaluation of the onset and magni-
tude of serum and oral fluid antibody isotype responses,
as well as the variation therein. Statistically significant dif-
ferences in viral replication and antibody responses were
observed among the three trials in both serum and oral
fluid specimens (Table 3). Since each trial included only
one virus isolate, statistically valid comparisons of the ef-
fects of virus isolates on PRRSV replication and antibody
responses were not possible. Nevertheless, the statistically
significant differences in virus replication and antibody re-
sponse observed among trials was consistent with previous
reports of virus isolate-dependent differences in the mag-
nitude of replication in pigs [16] and corresponding dif-
ferences in antibody response [16,17]. However, at the
individual boar level, the correlation between virus replica-
tion and antibody response was relatively weak. Thus, what
was true for the group of boars in a trial did not necessarily
apply to an individual boar.
The purpose of this study was to describe and contrast
the kinetics of PRRSV antibody in oral fluids and serum.
PRRSV serum IgM, IgA, and IgG were first detected in
samples collected on DPI 7, 10, and 10, respectively.
These results were compatible with prior reports de-
scribing the detection of PRRSV serum IgM between
DPI 5 and 7 [18-20], IgG between DPI 9 and 11 [19,21],
and IgA at DPI 14 [19]. PRRSV oral fluid IgM, IgA, and
IgG appeared concurrently with serum antibodies, but
collection of daily oral fluid samples provided more pre-
cise estimates. That is, oral fluid IgM, IgA, and IgG were
detected in samples collected between DPI 3 to 10, 7 to
10, and 8 to 14, respectively. There are no prior reports
on PRRSV oral fluid antibody kinetics in individual
animals with which to compare these results. However,
we previously reported the detection of PRRSV oral fluid
IgM and IgG in pen-based oral fluid samples from ex-
perimentally inoculated animals on DPI 7 [5]. Thus, the
PRRSV serum and oral fluid antibody responses observed
in this study were in agreement with prior observations
on PRRSV and our general understanding of the humoral
immune response as reflected in these sample matrices
[14,22]. Most significantly, this study provided a broader
foundation for understanding, developing, and interpreting
oral fluid antibody-based diagnostics in the context of the
humoral immune response.
Conclusions
This study demonstrated that anti-PRRSV antibody iso-
types can be detected in oral fluid specimens. These re-
sults were compatible with prior reports describing the
detection of anti-PRRSV antibody in both serum and
oral fluid. Detection of PRRSV antibody in oral fluids
collected from individual boars could provide an effec-
tive approach for monitoring PRRSV infection in boar
studs. Successful oral fluid collection and testing from
individual boars suggests that approach could also be ap-
plied to population in swine production systems, i.e.
pen-housed sows, farrowing crates, etc.
Methods
Experimental design
A total of 72 boars ranging from 6 months to 3.6 years
of age under the ownership of PIC North America
(Hendersonville, TN, USA) were used in this study.
Housing, feed rations, animal care guidelines, and experi-
mental protocols were approved and supervised by the
PIC USA Health Assurance and Welfare department. In 3
trials of 24 boars each, animals were intramuscularly (i.m.)
inoculated with either modified-live virus (MLV) PRRSV
vaccine (Trial 1), a Type 1 field isolate (Trial 2), or a Type
2 field isolate (Trial 3). Serum and oral fluid samples were
Table 3 Comparison of cumulative quantitative reverse transcription polymerase chain reaction (qRT-PCR) and
antibody responses (IgM, IgA, IgG) for 21 days following PRRSV inoculation1
Serum (mean AUC and 95% confidence intervals) Oral fluid (mean AUC and 95% confidence intervals)
Trial (virus isolate) qRT-PCR IgM IgA IgG qRT-PCR IgM IgA IgG
Trial 1: (IngelvacW PRRS MLV) 21.6b 46.6b 18.5b 17.4a 21.0b 27.6b 12.3b 25.1b
(18.8-24.5) (43.1-50.2) (14.6-22.6) (15.9-18.9) (17.0-25.1) (23.9-31.5) (7.7-17.0) (20.6-29.6)
Trial 2: (Type 1, D09-012332) 23.8b 39.5b 30.0a 18.3a 21.2b 17.6c 17.9b 21.9b
(21.2-26.6) (31.1-48.0) (23.2-36.9) (16.5-20.2) (18.1-24.3) (12.0-23.2) (10.9-24.9) (16.7-27.2)
Trial 3: (Type 2, MN-184) 38.1a 53.7a 31.6a 18.4a 31.6a 35.4a 26.2a 30.1a
(34.9-41.5) (48.1-59.3) (24.7-38.5) (17.1-19.85) (28.4-34.9) (28.6-42.3) (19.1-33.5) (25.3-34.9)
1 Individual boar PRRSV (loge geq/μl) and antibody (IgM, IgA, IgG) S/P responses over time were summarized as the area under the curve (AUC) prior to
performing the statistical analysis.
abc Superscripts within columns indicate statistically significant differences among means (Tukey’s Honestly Significant Differences test, p < 0.05).
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collected from all boars beginning 7 days prior to inocu-
lation and continuing through 21 days post inoculation
(DPI). After the completion of Trial 3, samples were
completely randomized and tested for PRRSV IgM, IgA,
and IgG antibody isotypes. Descriptive and comparative
statistical analyses were conducted to describe and com-
pare PRRSV antibody responses in serum and oral fluid
and evaluate differences among individual boars and be-
tween trials.
Animals and animal care
Boars were obtained from two Midwest USA breeding
stock sources documented to be free of PRRSV infection.
Culled boars (n = 24) ranged from one year to 3.6 years of
age and select boars (n = 48) ranged from 5 to 6 months of
age. The boars were housed in a commercial production fa-
cility equipped with nipple drinkers, concrete slatted floor-
ing, curtains, and tunnel ventilation. Feeder space, water
delivery, square footage per animal, sanitation, and ventila-
tion parameters met or exceeded PIC North America
health assurance and welfare requirements. Upon arrival,
animals were housed individually in crates (Hog Slat, Inc.,
Newton Grove, NC USA) and fed a commercial corn/soy
swine diet (Land O’ LakesW Farmland Feed, Roland, IA
USA) at a rate of 4 pounds per animal per day for acclima-
tion/training and 7 pounds per animal per day thereafter.
Porcine reproductive and respiratory syndrome viruses
In Trial 1, 24 boars were inoculated i.m. with 2 ml
of a commercial MLV vaccine (IngelvacW PRRS MLV,
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO
64506) rehydrated and administered according to the
instructions provided by the manufacturer. In Trial 2,
24 boars were inoculated i.m. with 2 ml of a Type 1
PRRSV (isolate D09-012131) at an estimated concen-
tration of 1 × 105.5 median tissue culture infectious
dose (TCID50) per ml. Isolate D09-012131 was isolated
from serum samples submitted to the University of
Minnesota Veterinary Diagnostic Laboratory (St. Paul, MN
USA) in March 2009 as part of a routine monitoring pro-
gram in a sow herd located in Illinois USA and propagated
on pulmonary alveolar macrophage cells, as described else-
where [11]. In Trial 3, 24 boars were IM inoculated with
2 ml of a Type 2 PRRSV isolate (MN-184, GenBank acces-
sion no. AY656992) at a concentration of 1 × 104.5 TCID50
per ml. Isolate MN-184 (kindly provided by Dr. Scott
Dee, University of Minnesota) was propagated on MARC-
145 cells [23].
Sample collection
Oral fluid collection
Oral fluid samples were collected daily from individually-
housed boars beginning 7 days prior to inoculation and
continuing through 21 days post inoculation (DPI) using
a procedure described by Kittawornrat et al. [11]. In brief,
oral fluid samples were collected by allowing boars to
chew on 1.6 cm (5/8”) cotton rope (Web Rigging Supply,
Inc., Lake Barrington, IL USA). Prior to collection, ropes
were soaked with a solution of sucrose and apple juice
(unsweetened apple juice with 50% (v/v) sucrose) and then
air-dried. To collect oral fluid samples, ropes were placed
in “rope holders” fixed at the front of each pen for
20 minutes. Oral fluids were deposited as the boars
chewed on the rope. To recover the oral fluid specimens,
the bottom 15 cm (~6”) of the rope (wet portion) was
inserted into a 3.8 liter (one gallon) re-sealable plastic bag
and severed from the dry portion of the rope. The bag
with the wet rope inside was passed through a wringer
(Dyna-Jet Products, Overland Park, KS USA), causing the
fluid to pool in the bottom of the bag. Samples were then
decanted into a 50 ml centrifuge tube and the volume re-
corded. Thereafter, samples were centrifuged at 1,000 × g
for 10 minutes at 4°C, aliquoted into 5 ml plastic tubes
(Becton, Dickinson and Company, Bedford, MA USA),
and stored at −80°C until assayed.
Serum collection
In each trial, serum samples were collected from all
boars on DPI −7, 0, 7, 14, and 21. Additional serum
samples were collected on DPI 3, 5, 10, 17 from a subset
of boars (n = 4) randomly selected at the beginning of
each trial. Blood was collected by jugular venipuncture
using serum separation tubes (CorvacW, Tyco Healthcare
Group LP, Mansfield, MA USA). Samples were centrifuged
at 1,000 × g for 10 minutes and the serum was aliquoted
into 5 ml plastic tubes (Becton, Dickinson and Company)
and stored at −80°C until assayed.
PRRSV antibody ELISAs
Commercial PRRSV serum antibody ELISA All serum
samples were assayed for PRRSV antibodies using a com-
mercial indirect ELISA (PRRS X3 Ab Test, IDEXX Labora-
tories, Inc., Westbrook, ME USA) performed according
to the manufacturer’s instruction. As recommended by the
manufacturer, a positive result was defined as a sample-to-
positive (S/P) ratio ≥ 0.4. Modifications to the commercial
serum ELISA for the detection of antibody isotypes in
serum and oral fluid are described below and listed in
Table 4.
PRRSV antibody isotypes in serum The commercial
indirect ELISA (PRRS X3 Ab Test) was modified to de-
tect PRRSV-specific IgM, IgA, and IgG antibody iso-
types in serum. In brief, serum samples were diluted
1:40 (5 μl serum sample + 195 μl kit diluent) for IgM
and IgG and 1:5 (40 μl serum sample + 160 μl kit dilu-
ent) for IgA. 100 μl of diluted serum was then transferred
Kittawornrat et al. BMC Veterinary Research 2013, 9:61 Page 7 of 11
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to the PRRSV antigen-coated plates and incubated for
30 minutes at 22°C. After washing 3 times with 1X kit
wash solution (400 μl), appropriately diluted horseradish
peroxidase (HRPO)-conjugated anti-pig immunoglobulin
(Ig) antibody (IgM (A100-100P), IgA (A100-102P), or IgGFc
(A100-104P) (Bethyl Laboratories, Montgomery, TX USA)
was added to each well and incubated for 30 minutes
at 22°C. Thereafter, plates were washed three times with
kit washing solution, after which 100 μl of tetramethyl-
benzidine (TMB) was added to each well and the plates
incubated at 22°C for 15 minutes. At precisely 15 minutes,
100 μl of kit stop solution was added to each well. The
plates were read at 650 nm using an ELISA plate reader
(EL800 micro plate reader, Bio TekW Instruments Inc.,
Winooski, VT) controlled by commercial software (Gen5™
Bio TekW Instruments Inc., Winooski, VT USA) and the
reactions measured as optical density (OD).
PRRSV antibody isotypes in oral fluid Modification
of the commercial PRRSV ELISA for the detection of
PRRSV-specific IgM, IgA, and IgG antibody in swine
oral fluid has previously been described [5]. In brief, oral
fluid samples were diluted 1:2 (150 μl oral fluid sample +
150 μl kit diluent). 250 μl of diluted oral fluid was then
transferred to PRRSV antigen-coated plates and incubated
for 16 hours at 4°C. Thereafter, the plates were washed
three times with 400 μl of 1X kit wash solution. To detect
the reaction, 100 μl of a solution containing appropriately
diluted HRPO-conjugated anti-pig Ig (M, A, or G) was
added to each well and the plates incubated for 30 minutes
at 22°C. The procedure for determining the optimal dilu-
tion of secondary antibody is described in preparation
of secondary antibody section. After washing three times,
100 μl of TMB was added to each well and the plates
incubated at 22°C for 15 minutes. Finally, 100 μl of kit
stop solution was added to each well. As described in
preparation of secondary antibody section, the plates were
read at 650 nm and the reactions measured as optical
density (OD).
Preparation of secondary antibody
To assure assay repeatability, the concentration of anti-
pig Ig (M, A, or G) was standardized using the positive
control OD value listed in the manufacturer’s Certificate
of Analysis as the benchmark. The general procedure for
calculating the conjugate dilution was as follows: 4 dilu-
tions of anti-pig Ig (M, A, or G) were prepared in bottles
wrapped in aluminum foil using diluent provided by manu-
facturer (IDEXX Laboratories, Inc., Westbrook, MA USA)
and then stirred for 48 hours at 4°C. The reactivity of the 4
dilutions was determined using negative and positive kit
controls. Specifically, kit negative control was dispensed
into 48 wells (one-half plate) and kit positive control in
each of the remaining 48 wells. Negative control OD values
Table 4 Summary of porcine reproductive and respiratory syndrome virus (PRRSV) serum and oral fluid antibody
enzyme linked-immunosorbent assay (ELISA) conditiona
IgM IgA IgG Commercial ELISA
Serum ELISAs
Sample dilution 1:40 1:5 1:40 1:40
Sample volume 100 μl 100 μl 100 μl 100 μl
Conjugate dilution 1:5,000b 1:1,000c 1:15,000d Provided with kit
Negative control 100 μl of pooled negative
serum diluted 1:40
100 μl of pooled negative
serum diluted 1:5
100 μl of kit
negative control
100 μl of kit
negative control
Positive control 100 μl of pooled serum
from DPI 7 diluted 1:40
100 μl of pooled serum
from DPI 21 diluted 1:5
100 μl of kit
positive control
100 μl of kit
positive control
Oral fluid ELISAs
Sample dilution 1:2 1:2 1:2
Sample volume 250 μl 250 μl 250 μl
Conjugate dilution 1:3,800b 1:2,000c 1:2,400d
Negative control 250 μl of reference standard
oral fluide DPI 0 diluted 1:2
250 μl of reference standard
oral fluide DPI 0 diluted 1:2
100 μl of kit negative
control diluted 1:30
Positive control 250 μl of reference standard
oral fluide DPI 10diluted 1:5
250 μl of reference standard
oral fluide DPI 91 diluted 1:2
100 μl of kit positive
control diluted 1:30
a Oral fluid ELISA conditions represent modifications to a commercial PRRSV serum antibody ELISA protocol (IDEXX PRRS X3 Ab Test, IDEXX Laboratories, Inc.,
Westbrook, ME, USA).
b Anti-pig IgM: HRPO conjugate (A100-100P, Bethyl Laboratories, Montgomery, TX, USA).
c Anti-pig IgA: HRPO conjugate (A100-102P, Bethyl Laboratories, Montgomery, TX, USA).
d Anti-pig IgGFc: HRPO conjugate (A100-104P, Bethyl Laboratories, Montgomery, TX, USA).
e Reference standard oral fluid samples have been previously described [5].
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were used to screen for non-specific reactions and positive
control OD values were used to determine the equation
of the line:
y ¼ axþ c ð1Þ
where (y) is the anti-pig Ig (M, A, or G) OD response, (a) is
the slope of the line, (x) is the dilution of anti-pig Ig (M, A,
or G), and (c) is the intercept (Figure 4). Thereafter, the cor-
rect dilution of anti-pig Ig (M, A, or G) was calculated by
substituting the mean positive control OD from the Certifi-
cate of Analysis for “y” in Equation 1 and solving for “x”.
The general procedure for preparing the appropriate
dilution of anti-pig Ig (M, A, or G) was modified for
serum and oral fluid antibody ELISAs. In this study, all
serum and oral fluid specimens were tested on a single
lot of ELISA kits. Thus, the appropriate dilution of anti-
pig Ig was calculated specifically for the PRRSV indirect
ELISA (PRRS X3 Ab Test) kit lot (#99-40959-W721).
For the serum ELISA, the correct dilution of anti-pig
IgGFc was determined by titrating 4 dilutions of anti-pig
IgGFc (1:14,000, 1:14,500, 1:15,000, 1:15,500) against 100 μl
of kit positive control and generating the equation of the
line, as described above. The appropriate dilution of anti-
pig IgM was determined by titrating 4 dilutions of second-
ary antibody (1:4,000, 1:4,500, 1:5,000, 1:5,500) against
100 μl of a positive control consisting of a 1:40 dilution of
a pool of serum from 72 boars at DPI 7. For anti-pig IgA,
4 dilutions (1: 1,000, 1:2,500, 1:3,000, 1:3,500) were titrated
against 100 μl of a positive control consisting of a 1:5 dilu-
tion of a pool of serum from 72 boars at DPI 21. Diluted
conjugate was simultaneously titrated against negative
controls, i.e., kit negative control for anti-pig IgGFc and a
pool of serum from 72 boars at DPI 0 for anti-pig IgA
(1:5) and anti-pig IgM (1:40).
The protocol for preparing the optimal secondary anti-
body dilution for the PRRSV oral fluid ELISA has been
described elsewhere [5]. To prepare anti-pig IgGFc, 4
conjugate dilutions (1:1,000, 1:1,500, 1:2,000, 1:2,500)
were titrated against 100 μl of kit negative and positive
controls diluted 1:30 (10 μl kit control + 290 μl kit sample
diluent). Controls for anti-pig IgM and anti-pig IgA con-
sisted of oral fluid samples from PRRSV-negative pigs
vaccinated with 2 ml of PRRS modified live virus (MLV)
vaccine (IngelvacW PRRS MLV, Boehringer Ingelheim
Vetmedica, Inc., St. Joseph, MO USA). The sample col-
lected immediately prior to vaccination was used as nega-
tive control. Samples collected on 10 and 56 days post
vaccination were used as positive controls for anti-pig IgM
and anti-pig IgA conjugates, respectively. Four dilutions of
anti-pig IgM (1: 3,000, 1:3,500, 1:4,000, 1:4,500) and anti-
pig IgA (1:1,000, 1:1,500, 1:2,000, 1:2,500) were used to cal-
culate appropriate dilution, as described previously.
Quantitative reverse transcription polymerase chain
reaction (qRT-PCR)
Detailed qRT-PCR protocols for serum and oral fluids are
reported elsewhere [11,24]. In brief, nucleic acid extraction
from serum and oral fluid samples was performed using a
commercial RNA extraction kit (AmbionW MagMax™-96
Viral RNA isolation kit, Applied Biosystems™, Foster City,
CA USA). Real-time PCR was performed with commercial
reagent sets (TaqMANW NA and EU PRRSV Reagents
and TaqMANW NA and EU PRRSV Controls, Applied
Biosystems™) using the following cycling conditions: 1 cycle
at 45°C for 10 minutes, 1 cycle at 95°C for 10 minutes,
40 cycles of: 97°C for 2 seconds, 60°C for 40 seconds. Eight
10-fold serially-diluted (100 to 107 copies/μl) plasmid-
derived commercial standards (TaqMANW NA and EU
PRRSV RNA controls, Applied Biosystems™) were run on
each PCR plate and their Ct values used to derive a stand-
ard curve. Samples were quantified as genome equivalents
per μl (geq/μl) by fitting the sample Cts to the standard
curve using the AB7500 Fast System SDS Software (Applied
Biosystems™).
Statistical analysis
All optical density (OD) data were converted to sample-
to-positive (S/P) ratios prior to statistical analysis using
the following formula:
S=P ¼ Sample A 650ð Þ–NC½ = PC–NCð Þ ð2Þ
where NC and PC represented the mean OD of the two
negative control wells and two positive control wells,
Figure 4 Calculation of the optimal dilution of anti-pig
secondary antibody for PRRSV IgM, IgA, IgG ELISAs. The
relationship between the positive control optical density (OD) and
dilution of anti-pig secondary antibody was plotted as y = ax + c,
where (y) is the secondary antibody OD response, (a) is the slope of
the line, (x) is the dilution of secondary antibody, and (c) is the
intercept. The appropriate dilution corresponds to the positive
control value provided in the Certificate of Analysis.
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respectively. Statistical analyses were performed using
SASW Version 9.2 (SASW Institute Inc., Cary, NC USA)
and MedCalcW 12.3.0.0 (MedCalc Software, Mariakerke
Belgium).
Initially, descriptive and comparative analyses were
conducted to describe the onset, magnitude, and dura-
tion of PRRSV antibody isotype S/P ratios in serum and
oral fluid. Thereafter, S/P results were analyzed in a lin-
ear mixed model with repeated measures (SASW PROC
GLIMMIX) using trial (1, 2, 3), DPI, boar age (month),
oral fluid volume (ml), and their pairwise interactions as
fixed effects and “boar” as the subject of repeated mea-
sures. Tukey’s Honestly Significantly Difference (HSD)
test was used to detect statistically significant differences
between S/P ratios in each trial by DPI. Pearson’s cor-
relation coefficient (SASW PROC CORR) was used to
evaluate the overall quantitative relationship between
IgM, IgA, and IgG S/P ratios in serum and oral fluid
samples. Defining an S/P ratio ≥ 0.4 as positive [5],
McNemar’s test (SASW PROC FREQ) for paired samples
was used to determine whether the proportion IgG
ELISA positive serum and oral fluid samples were sig-
nificantly different by trial (1, 2, 3) and DPI.
The association between the level of PRRSV replica-
tion and the strength of the humoral response was eval-
uated in individual boars. The virus concentration (loge
geq/μl) and antibody isotype S/P responses (IgM, IgA,
IgG) in serum and oral fluid over the course of the ex-
periment were re-expressed as the area under the curve
(AUC; MedCalcW) and evaluated using
Pearson’s Correlation Coefficient (SASW PROC CORR).
In addition, the AUC data were evaluated for statistically
significant differences among sample types (serum, oral
fluid), trials (1, 2, 3), and quantitative responses (PRRSV,
IgM, IgA, IgG) by analysis of variance (ANOVA). Sample
type, trial, response, and their interaction were used as
fixed effects in the model. Thereafter, Tukey’s Honestly
Significant Differences (HSD) test was used to test for sta-
tistically significant differences among trial means.
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